Manya Magnus, Ph.D., M.P.H., L.P.N.

Manya Magnus is an Associate Professor.

Dr. Magnus is co-director of the School's MPH Epidemiology Program and co-director of the Graduate Certificate in HIV/AIDS Studies. Always interested in integrating research with clinical care, Dr. Magnus has managed an array of epidemiologic studies, including randomized controlled clinical trials, cohort studies, and case-control studies. She now applies epidemiologic methodology to evaluate national programs, including CDC-sponsored surveillance systems and Special Projects of National Significance (SPNS) funded by the HIV/AIDS Bureau (HAB) of the Health Services Resources Administration (HRSA). Dr. Magnus also participates in a variety of other HIV-related research activities.

Master of Public Health (Epidemiology), Tulane University School of Public Health and Tropical Medicine, 1998 Doctor of Philosophy (Epidemiology), Tulane University, 2001

PubH 250-Epidemiology of HIV/AIDS, Department of Epidemiology and Biostatistics PubH 203-Principles and Practice of Epidemiology, Department of Epidemiology and Biostatistics

The primary focus of Dr. Magnus's research is HIV/AIDS among women, children, adolescents and other vulnerable populations, and includes clinical trials, observational studies, behavioral surveillance, and innovative approaches to evaluation research. A side interest is maternal-child health, specifically infertility and decision-making behavior among pregnant women. Dr. Magnus is the Principal Investigator (PI) of the National HIV Behavioral Surveillance study, conducted as a part of the Public Health-Academic Partnership between GWU Department of Epidemiology and Biostatistics and the District of Columbia Department of Health/HIV/AIDS Administration. As a part of this Partnership, Dr. Magnus is the Co-PI of an evaluation of the District of Columbia Routine Testing Initiative. With collaborators in Louisiana, Dr. Magnus is evaluating the impact of a statewide electronic database for linkage of TB-, syphilis-, and HIV-infected individuals seeking care in Louisiana as a part of a HRSA/HAB SPNS grant as well as the evaluation of a statewide telemedicine program in the state of Louisiana. Also with HRSA/HAB SPNS funds, she directs the multi-site evaluation of eight programs that are developing innovative methods for outreach, linkage, and retention in care of HIV-infected adolescents of color.

Dr. Magnus has been a member of site operations committees of the national Pediatric AIDS Clinical Trials Group, served on the Tulane University Committee on Use of Human Subjects, on the Maternal-Child Community Advisory Board, and on the WORD UP/NHBS Community Advisory Board.